orphan
Opioids built on a morphinan core.
- Drugs containing orphan: 24
- Approved somewhere: 13
- With a US drug page: 11
- Stem
- orphan
- Class
- Opioids built on a morphinan core
- Sub-stems
- -orph-
Approved and clinical-stage drugs in ChEMBL whose names containing orphan or one of its sub-stems, matched by spelling; those with a US drug page link to it.
| Acts on | |||
|---|---|---|---|
| Butorphanol | Approved | OPRM1, OPRK1 | Mu opioid receptor partial agonist |
| Levorphanol | Early phase 1 | OPRM1 | Mu opioid receptor agonist |
| Levallorphan | — | OPRM1, OPRK1 | Mu opioid receptor antagonist |
| Dextromethorphan | Approved | SIGMAR1, GRIN2A | Sigma opioid receptor agonist |
| Samidorphan | Approved | OPRM1, OPRK1, OPRD1 | Mu opioid receptor antagonist |
| Methylsamidorphan | Phase 2 | OPRM1 | Mu opioid receptor antagonist |
| Apomorphine | Approved | D2-like dopamine receptor | D2-like dopamine receptor agonist |
| Chlorpheniramine | Approved | HRH1 | Histamine H1 receptor antagonist |
| Dichlorphenamide | Approved | CA1, CA2, CA12, CA4 | Carbonic anhydrase I inhibitor |
| Hydromorphone | Approved | OPRM1 | Mu opioid receptor agonist |
| Morphine | Approved | OPRM1 | Mu opioid receptor agonist |
| Oxymorphone | Approved | Opioid receptors; mu/kappa/delta | Opioid receptors; mu/kappa/delta agonist |
| Chlorphenesin carbamate | Phase 1 | — | Unknown |
| Chlorphentermine | — | SLC6A4 | Serotonin transporter substrate |
| Buprenorphine | Approved | OPRM1, OPRK1 | Mu opioid receptor agonist |
| Chlorphenoxamine | Approved | HRH1 | Histamine H1 receptor antagonist |
| Dexchlorpheniramine | Approved | HRH1 | Histamine H1 receptor antagonist |
| Diacetylmorphine | Approved | OPRM1 | Mu opioid receptor agonist |
| Nicomorphine | Phase 2 | — | — |
| Asalhydromorphone | Phase 1 | — | — |
| Norbuprenorphine | Phase 1 | — | — |
| Tetraphenylporphine tetrasulfonic acid | Phase 1 | — | — |
| Ethylmorphine | — | — | — |
| Morpholine salicylate | — | — | — |
Stem from WHO, The use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances (2024); description written by Arca. Drugs, stages, targets and mechanisms from ChEMBL (CC BY-SA 3.0). WHO